|
gptkbp:instance_of
|
gptkb:castle
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:castle
|
|
gptkbp:affects
|
lymph nodes
multiple lymph node regions
|
|
gptkbp:can_be
|
gptkb:fandom
thrombocytopenia
hypergammaglobulinemia
|
|
gptkbp:can_lead_to
|
immune system dysfunction
lymphadenopathy
|
|
gptkbp:caused_by
|
fatigue
weight loss
fever
night sweats
|
|
gptkbp:current_use
|
requires multidisciplinary management
|
|
gptkbp:disease_resistance
|
gptkb:theorem
|
|
gptkbp:focuses_on
|
research studies
|
|
gptkbp:has_achievements
|
organ dysfunction
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
multicentric Castleman disease
|
|
gptkbp:is_affected_by
|
viral infections
|
|
gptkbp:is_associated_with
|
gptkb:healthcare_organization
increased risk of infections
autoimmune disorders
HIV infection
|
|
gptkbp:is_characterized_by
|
systemic symptoms
enlarged lymph nodes
interleukin-6 elevation
lymphoproliferation
|
|
gptkbp:is_distinct_from
|
gptkb:unicentric_Castleman_disease
|
|
gptkbp:is_involved_in
|
plasma cells
vascular proliferation
|
|
gptkbp:is_known_for
|
MCD
|
|
gptkbp:is_linked_to
|
cytokine release syndrome
|
|
gptkbp:is_often_depicted_as
|
other lymphoproliferative disorders
|
|
gptkbp:is_often_used_in
|
adults
|
|
gptkbp:is_recognized_by
|
gptkb:the_World_Health_Organization
|
|
gptkbp:is_studied_in
|
clinical trials
|
|
gptkbp:is_used_for
|
splenomegaly
|
|
gptkbp:managed_by
|
supportive care
|
|
gptkbp:requires
|
gptkb:vaccine
palliative care
long-term follow-up
|
|
gptkbp:scientific_classification
|
idiopathic
|
|
gptkbp:social_responsibility
|
imaging studies
biopsy
|
|
gptkbp:treatment
|
gptkb:hospital
gptkb:rituximab
chemotherapy
corticosteroids
hematologists
specialized centers
|
|
gptkbp:type_of
|
gptkb:non-Hodgkin_lymphoma
|